Skip to main content
Fig. 2 | Thrombosis Journal

Fig. 2

From: Vitamin K antagonist use: evidence of the difficulty of achieving and maintaining target INR range and subsequent consequences

Fig. 2

Risks of adverse outcomes for people with INRs <2.0 or >3.0. Adapted from data from an observational study using the Veterans Health Administration dataset [38] showing the relative risk (RR) of adverse thrombotic or embolic events in patients with subtherapeutic INRs versus normal INRs and then major bleeding vents with supertherapeutic INRs versus normal INRs. The diamond represents the actual RR with the line representing the 95 % confidence interval and the blue dashed line representing a RR of 1.0, where the risk of outcomes would have been the same as those with normal INRs

Back to article page

Thrombosis Journal

ISSN: 1477-9560

Contact us